A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhydrosis

Trial Profile

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhydrosis

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Glycopyrrolate (Primary)
  • Indications Hyperhidrosis
  • Focus Registrational; Therapeutic Use
  • Acronyms ATMOS-1
  • Sponsors Dermira
  • Most Recent Events

    • 13 Sep 2017 Results from ATMOS-1 and ATMOS-2 trials published in a Dermira media release.
    • 07 Sep 2017 According to Dermira media release, data from two phase III (ATMOS-1 & ATMOS-2) studies will be presented at the 26th European Academy of Dermatology and Venereology (EADV) Congress
    • 03 Mar 2017 Results published in a Dermira media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top